ARCA biopharma Stock (NASDAQ:ABIO)


RevenueOwnershipFinancialsChart

Previous Close

$2.50

52W Range

$2.25 - $53.88

50D Avg

$39.21

200D Avg

$30.93

Market Cap

$34.82M

Avg Vol (3M)

$13.86K

Beta

0.90

Div Yield

$3.18 (72.73%)

ABIO Company Profile


ARCA biopharma, Inc., a clinical-stage biopharmaceutical company, develops and commercializes genetically targeted therapies for cardiovascular diseases. Its lead product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), which is in Phase IIb clinical trial for the treatment for COVID-19; and Gencaro (bucindolol hydrochloride), a pharmacogenetically-targeted beta-adrenergic receptor antagonist that has completed Phase IIb trial for the treatment of atrial fibrillation in patients with chronic heart failure. ARCA biopharma, Inc. has a collaboration agreement with LabCorp to develop genetic test for GENETIC-AF clinical trial; and research collaboration with Colorado Prevention Center, the University of Colorado's Academic Research Organization to develop and commercialize Gencaro. The company was incorporated in 2004 and is headquartered in Westminster, Colorado.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

3

IPO Date

Aug 08, 1997

Website

ABIO Performance


ABIO Financial Summary


Dec 23Dec 22Dec 21
Revenue---
Operating Income$-7.30M$-10.60M$-19.34M
Net Income$-5.34M$-9.26M$-19.23M
EBITDA$-7.30M$-10.60M$-19.32M
Basic EPS-$-0.64$-1.38
Diluted EPS-$-0.64$-1.38

Fiscal year ends in Dec 23 | Currency in USD

Peer Comparison


TickerCompany
SIOXSio Gene Therapies Inc.
MGTADianthus Therapeutics, Inc.
NXTCNextCure, Inc.
KTTAPasithea Therapeutics Corp.
AVTEAerovate Therapeutics, Inc.
ACRVAcrivon Therapeutics, Inc. Common Stock
CTMXCytomX Therapeutics, Inc.
SPROSpero Therapeutics, Inc.
QNRXQuoin Pharmaceuticals, Ltd.
ANTXAN2 Therapeutics, Inc.
RNXTRenovoRx, Inc.
RZLTRezolute, Inc.
INDPIndaptus Therapeutics, Inc.
TPSTTempest Therapeutics, Inc.
ADAGAdagene Inc.
NLTXNeurogene Inc.
FBRXForte Biosciences, Inc.
TILInstil Bio, Inc.